Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Antiobesity pharmacotherapy for patients with type 2 diabetes: focus on long-term management.

Jeon WS, Park CY.

Endocrinol Metab (Seoul). 2014 Dec 29;29(4):410-7. doi: 10.3803/EnM.2014.29.4.410. Review.

PMID:
25559569
2.

Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P.

CMAJ Open. 2014 Oct 1;2(4):E306-17. doi: 10.9778/cmajo.20140012. eCollection 2014 Oct.

PMID:
25485258
3.

Obesity in primary care: prevention, management and the paradox.

Haslam D.

BMC Med. 2014 Aug 26;12:149. doi: 10.1186/1741-7015-12-149.

PMID:
25154409
4.

Does orlistat cause acute kidney injury?

Beyea MM, Garg AX, Weir MA.

Ther Adv Drug Saf. 2012 Apr;3(2):53-7. doi: 10.1177/2042098611429985. Review.

PMID:
25083225
5.

Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate.

Sweeting AN, Tabet E, Caterson ID, Markovic TP.

Diabetes Metab Syndr Obes. 2014 Feb 12;7:35-44. doi: 10.2147/DMSO.S38979. eCollection 2014. Review.

PMID:
24550678
6.

Acute oxalate nephropathy associated with orlistat: a case report with a review of the literature.

Chaudhari D, Crisostomo C, Ganote C, Youngberg G.

Case Rep Nephrol. 2013;2013:124604. doi: 10.1155/2013/124604. Epub 2013 May 8.

PMID:
24527242
7.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

PMID:
24231879
8.

New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).

Henry RR, Chilton R, Garvey WT.

J Diabetes Complications. 2013 Sep-Oct;27(5):508-18. doi: 10.1016/j.jdiacomp.2013.04.011. Epub 2013 May 28. Review.

PMID:
23726071
9.

A natural fiber complex reduces body weight in the overweight and obese: a double-blind, randomized, placebo-controlled study.

Grube B, Chong PW, Lau KZ, Orzechowski HD.

Obesity (Silver Spring). 2013 Jan;21(1):58-64. doi: 10.1002/oby.20244.

PMID:
23505169
10.

Assessment of Antiobesity Potential of Achyranthes aspera Linn. Seed.

Rani N, Sharma SK, Vasudeva N.

Evid Based Complement Alternat Med. 2012;2012:715912. doi: 10.1155/2012/715912. Epub 2012 Jun 27.

PMID:
22919417
11.

Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials.

Zhou YH, Ma XQ, Wu C, Lu J, Zhang SS, Guo J, Wu SQ, Ye XF, Xu JF, He J.

PLoS One. 2012;7(6):e39062. doi: 10.1371/journal.pone.0039062. Epub 2012 Jun 20. Review.

PMID:
22745703
12.

Anti-Obesity Drugs: A Review about Their Effects and Safety.

Kang JG, Park CY.

Diabetes Metab J. 2012 Feb;36(1):13-25. doi: 10.4093/dmj.2012.36.1.13. Epub 2012 Feb 17.

PMID:
22363917
13.

Inhibition of key digestive enzymes by cocoa extracts and procyanidins.

Gu Y, Hurst WJ, Stuart DA, Lambert JD.

J Agric Food Chem. 2011 May 25;59(10):5305-11. doi: 10.1021/jf200180n. Epub 2011 Apr 26.

PMID:
21495725
14.
15.

Pharmacotherapies for obesity: past, current, and future therapies.

Ioannides-Demos LL, Piccenna L, McNeil JJ.

J Obes. 2011;2011:179674. doi: 10.1155/2011/179674. Epub 2010 Dec 12.

PMID:
21197148
16.

Very low calorie diet (VLCD) followed by a randomized trial of corset treatment for obesity in primary care.

Wikstrand I, Torgerson J, Boström KB.

Scand J Prim Health Care. 2010 Jun;28(2):89-94. doi: 10.3109/02813431003778540.

PMID:
20429742
17.

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis.

Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Gravallese EA, Erondu NE, Heymsfield SB, Nguyen AM.

Obes Rev. 2009 May;10(3):333-41. doi: 10.1111/j.1467-789X.2009.00567.x. Epub 2009 Mar 6. Review.

PMID:
19389060
18.

Industry funding and the reporting quality of large long-term weight loss trials.

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB.

Int J Obes (Lond). 2008 Oct;32(10):1531-6. doi: 10.1038/ijo.2008.137. Epub 2008 Aug 19. Review.

PMID:
18711388
19.

Orlistat in the prevention of diabetes in the obese patient.

Mancini MC, Halpern A.

Vasc Health Risk Manag. 2008;4(2):325-36. Review.

PMID:
18561508
20.

Pediatric obesity: parallels with addiction and treatment recommendations.

Acosta MC, Manubay J, Levin FR.

Harv Rev Psychiatry. 2008;16(2):80-96. doi: 10.1080/10673220802069764. Review.

PMID:
18415881
Items per page

Supplemental Content

Write to the Help Desk